UroGen Pharma Ltd. (URGN) Institutional Ownership & Insider Trading
187 institutions reported holding UroGen Pharma Ltd. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 16 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
URGNUroGen Pharma Ltd.Follow URGN — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters187 institutions held 86.7% of the shares. Across filers that reported both quarters, shares held changed -8.6%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 187 | 42 | -8.6% | 56 | 38 | 50 | 14 |
| Mar 26 | 171 | 46 | +6.2% | 47 | 24 | 46 | 25 |
| Dec 25 | 165 | 44 | -0.4% | 47 | 28 | 47 | 22 |
| Sep 25 | 157 | 44 | +9.4% | 43 | 30 | 43 | 20 |
| Jun 25 | 149 | 40 | -4.4% | 43 | 37 | 36 | 27 |
| Mar 25 | 140 | 42 | +14.8% | 42 | 14 | 47 | 16 |
| Dec 24 | 138 | 36 | +4.0% | 39 | 22 | 38 | 16 |
| Sep 24 | 128 | 35 | -13.5% | 46 | 23 | 27 | 11 |
UroGen Pharma Ltd. — questions
- Who owns UroGen Pharma Ltd. stock?
- 187 institutions reported UroGen Pharma Ltd. shares in 13F filings for the quarter ended 2026-06-30. The largest: RTW INVESTMENTS, LP (9.3%), BlackRock, Inc. (6.5%), MORGAN STANLEY (5.3%).
- Are UroGen Pharma Ltd. insiders buying or selling?
- 16 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from UroGen Pharma Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.